ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $737,092 | +88.2% | 20,670 | +34.1% | 0.81% | +69.0% |
| Q1 2023 | $391,617 | -64.0% | 15,418 | -42.6% | 0.48% | -54.9% |
| Q4 2022 | $1,089,158 | +60.2% | 26,853 | +20.8% | 1.06% | +57.2% |
| Q3 2022 | $680,000 | -0.7% | 22,235 | +14.4% | 0.68% | +7.0% |
| Q2 2022 | $685,000 | -6.5% | 19,444 | +22.0% | 0.63% | +18.8% |
| Q1 2022 | $733,000 | +184.1% | 15,933 | +309.3% | 0.53% | +199.4% |
| Q4 2021 | $258,000 | -96.2% | 3,893 | -95.6% | 0.18% | -89.3% |
| Q4 2020 | $6,766,000 | -11.8% | 88,183 | -50.5% | 1.66% | -27.0% |
| Q3 2020 | $7,673,000 | -0.3% | 178,183 | 0.0% | 2.27% | -11.5% |
| Q2 2020 | $7,696,000 | +216.4% | 178,183 | +110.8% | 2.57% | +151.7% |
| Q1 2020 | $2,432,000 | – | 84,537 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |